2020 Central Nervous System (CNS) Tumours

Scheme description
Testing for 1p/19q co-deletion status and MGMT promotor methylation and IDH1 / IDH2 status. Additional test information is provided for each case.
Disorders/Gene target(s)
CNS Tumours
Oligodendroglioma
Astrocytoma
Glioblastoma
Glioma
Clinical cases
4
Testing/analysis
Any
Sample type
Formalin fixed paraffin-embedded tissue
Techniques
FISH and Molecular Techniques
Assessment
Analytical, Interpretation and Clerical Accuracy
Eligibility
All laboratories worldwide
Languages
English
ISO17043 Accredited EQA
Yes
EQA timeline
Sample dispatchOctober 2020
Testing period6 weeks
Assessment resultsFebruary 2021
Final Summary reportApril 2021
Other information
Fee
£375.00
GenQA code
2020CNS
« Return to EQA scheme list
Go to top